Patent · US Active

Anti-DLL3 antibodies

US9353182B2 · kind B2 · utility

8Cited by
46References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2015
Grant dateMay 31, 2016
Priority date—
Expiry dateSep 18, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/70596
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.